Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab']
 presenting glofitamab follow up data for patients achieving cr (35% of treated). not yet able to conclude cure when considering data for #cart median follow up 11m. will wait for more #ash22 #carvsbite 
AML/ALL, CAR-T, stem cell transplant, global health oncology, advocacy. Thoughts are my own